Your browser doesn't support javascript.
loading
Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis.
Claiborne, Daniel T; Scully, Eileen P; Palmer, Christine D; Prince, Jessica L; Macharia, Gladys N; Kopycinski, Jakub; Michelo, Clive M; Wiener, Howard W; Parker, Rachel; Nganou-Makamdop, Krystelle; Douek, Daniel; Altfeld, Marcus; Gilmour, Jill; Price, Matt A; Tang, Jianming; Kilembe, William; Allen, Susan A; Hunter, Eric.
Afiliación
  • Claiborne DT; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
  • Scully EP; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Palmer CD; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
  • Prince JL; Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
  • Macharia GN; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.
  • Kopycinski J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.
  • Michelo CM; Zambia-Emory HIV Research Project, Lusaka, Zambia.
  • Wiener HW; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Parker R; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America.
  • Nganou-Makamdop K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Douek D; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Altfeld M; Virus Immunology Unit, Heinrich-Pette-Institut, Hamburg, Germany.
  • Gilmour J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom.
  • Price MA; International AIDS Vaccine Initiative, New York, New York, United States of America.
  • Tang J; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.
  • Kilembe W; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Allen SA; Zambia-Emory HIV Research Project, Lusaka, Zambia.
  • Hunter E; Zambia-Emory HIV Research Project, Lusaka, Zambia.
PLoS Pathog ; 15(8): e1007981, 2019 08.
Article en En | MEDLINE | ID: mdl-31449552
Despite extensive research on the mechanisms of HLA-mediated immune control of HIV-1 pathogenesis, it is clear that much remains to be discovered, as exemplified by protective HLA alleles like HLA-B*81 which are associated with profound protection from CD4+ T cell decline without robust control of early plasma viremia. Here, we report on additional HLA class I (B*1401, B*57, B*5801, as well as B*81), and HLA class II (DQB1*02 and DRB1*15) alleles that display discordant virological and immunological phenotypes in a Zambian early infection cohort. HLA class I alleles of this nature were also associated with enhanced immune responses to conserved epitopes in Gag. Furthermore, these HLA class I alleles were associated with reduced levels of lipopolysaccharide (LPS) in the plasma during acute infection. Elevated LPS levels measured early in infection predicted accelerated CD4+ T cell decline, as well as immune activation and exhaustion. Taken together, these data suggest novel mechanisms for HLA-mediated immune control of HIV-1 pathogenesis that do not necessarily involve significant control of early viremia and point to microbial translocation as a direct driver of HIV-1 pathogenesis rather than simply a consequence.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Replicación Viral / Genes MHC Clase I / Linfocitos T CD4-Positivos / Infecciones por VIH / Lipopolisacáridos / VIH-1 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Replicación Viral / Genes MHC Clase I / Linfocitos T CD4-Positivos / Infecciones por VIH / Lipopolisacáridos / VIH-1 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos